论文部分内容阅读
同种异体肾移植是目前国内外比较先进的医疗技术和科研项目之一。对挽救晚期尿毒症病人的生命有积极的意义。肾移植在20年代初已有动物实验报告。1936年Vororoy首次进行了肾功能很差,而且存活短暂的人体肾移植。50年代Harison成功地第一次在人体中将肾血管与髂血管吻合,同时将供肾者的输尿管接在受者的膀胱内。此方法沿用至今。但是由于存在着免疫排斥反应,往往导致肾移植术的失败。近20年来,随着免疫抑制药物的不断进展,如硫唑嘌呤、皮质激素、肝素、环磷酰胺等药在肾移植中的应
Allogeneic kidney transplantation is one of the more advanced medical technologies and research projects at home and abroad. To save the lives of patients with advanced uremia have a positive meaning. Kidney transplantation animal experiments have been reported in the early 1920s. In 1936, for the first time, Vororoy had poor renal function and short-lived human kidney transplants. In the 1950s, Harison succeeded in for the first time in the human body will renal blood vessels and iliac vessels anastomosis, while the ureter of the donor kidney connected to the recipient’s bladder. This method is still in use. However, due to the existence of immune rejection, often lead to the failure of renal transplantation. In recent 20 years, with the continuous progress of immunosuppressive drugs, such as azathioprine, corticosteroids, heparin, cyclophosphamide and other drugs in renal transplantation should